IMMX: Immix Biopharma, Inc. Stock

by  •  • Comments Off on IMMX: Immix Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 62.05
Enterprise Value ($M) 32.45
Book Value ($M) 27.63
Book Value / Share 1.05
Price / Book 2.25
NCAV ($M) 26.20
NCAV / Share 0.99
Price / NCAV 2.37

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -1.38
Return on Equity (ROE) -1.55

Liquidity (mrq)
Quick Ratio 5.82
Current Ratio 5.82

Balance Sheet (mrq) ($M)
Current Assets 32.92
Assets 34.35
Liabilities 6.72
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -16.14
Net Income -15.43
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -11.37
Cash from Investing -0.05
Cash from Financing 15.46

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-07 13G Hirschman Orin 5.80
08-30 13D Gkcc, Llc 19.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-16 16,497 53,251 30.98
2024-05-15 25,651 128,014 20.04
2024-05-14 29,694 90,258 32.90
2024-05-13 23,722 79,434 29.86

(click for more detail)

Similar Companies
ICCC – ImmuCell Corporation IKT – Inhibikase Therapeutics, Inc.
IMCC – IM Cannabis Corp. IMNM – Immunome, Inc.
IMNN – Imunon, Inc.


Financial data and stock pages provided by
Fintel.io